Company Monitoring Page for Amylin

latest headlines for company on cafepharma

Amylin target of renewed M&A murmurs
The Deal
Thu, 11/10/11 - 01:23 pm
Tags:
Amylin, M&A, Eli Lilly, Pfizer, Sanofi, GSK, Novo Nordisk
Insights from Amylin CEO on Split with Lilly
CNBC
Tue, 11/8/11 - 07:24 pm
Tags:
Amylin, Eli Lilly, diabetes, Daniel Bradbury
Blockbuster Breakup: Amylin Buys Out Lilly's Exenatide Rights
Motley Fool
Tue, 11/8/11 - 10:31 am
Tags:
diabetes, Eli Lilly, exenatide, Amylin
Is Amylin Pharmaceuticals the Perfect Stock?
Motley Fool
Mon, 10/24/11 - 11:04 am
Tags:
Amylin
Full of News, but Worth a 15% Gain? (Amylin)
Motley Fool
Sat, 10/22/11 - 12:27 pm
Tags:
Amylin, Byetta, diabetes, Novo Nordisk, Victoza
Lilly-Amylin’s Diabetes Drug Wins Approval for Expanded Use
Bloomberg
Thu, 10/20/11 - 09:04 am
Tags:
Eli Lilly, Amylin, Byetta, diabetes
Top Mid- And Large-Cap Biotech Picks By Legendary Fund Managers
Seeking Alpha
Fri, 10/14/11 - 11:41 am
Tags:
Alexion, Amgen, Amylin, Biogen Idec, Biomarin, Celgene, Gilead, Human Genome Sciences, Incyte, ONYX Pharmaceuticals, Seattle Genetics, Vertex, Theravance
8 Speculative Biotech Buys Based On Last Quarter's Biggest Movers
Seeking Alpha
Mon, 10/3/11 - 12:37 pm
Tags:
Achillion, Aeterna Zentaris, Antigenics, Ariad, Amylin, Amarin, BioDelivery Sciences, Cyclacel, Geron, Dendreon, PharmAthene, Zalicus, Human Genome Sciences, Keryx, Peregrine Pharmaceuticals, SIGA technologies, YM BioSciences
Novo Nordisk's Data at EASD
Yahoo/Zacks.com
Thu, 09/15/11 - 11:51 am
Tags:
Novo Nordisk, diabetes, EASD, Amylin, Eli Lilly, Merck, Victoza
Lilly, Amylin, Merck Diabetes Drug Risks Highlighted
Minyanville
Tue, 09/13/11 - 02:18 pm
Tags:
Merck, Eli Lilly, Amylin, diabetes, Bydureon, Alkermes, Victoza, Byetta, Novo Nordisk
Lilly/Amylin diabetes drug shows promise
Yahoo/InvestorsBusinessDaily
Tue, 09/13/11 - 10:12 am
Tags:
Eli Lilly, Amylin, Bydureon, diabetes
Amylin, Takeda call off obesity treatment
Bloomberg/Businessweek
Fri, 08/5/11 - 01:17 pm
Tags:
Takeda, pramlintide/metreleptin, obesity, Amylin
Amylin, Eli Lilly & Alkermes submit reply to US FDA on Bydureon
Pharmabiz
Sat, 07/30/11 - 12:31 pm
Tags:
Eli Lilly, Amylin, Alkermes, Bydureon, diabetes
Amylin Pharmaceuticals' CEO Discusses Q2 2011 Results - Earnings Call Transcript
Seeking Alpha
Tue, 07/26/11 - 04:38 pm
Tags:
earnings, Amylin
The 15 Most-Watched BioPharma Stocks
Motley Fool
Wed, 07/13/11 - 04:53 pm
Tags:
MannKind, Celgene, Amarin, Vertex Pharmaceuticals, BioSante, Keryx, Amylin, Regeneron, Immunogen, Cubist Pharmaceuticals, Isis Pharmaceuticals, Sunesis, OPKO Health, SciClone, Cephalon
Amylin to Resubmit Diabetes Treatment to F.D.A.
NY Times
Sun, 07/10/11 - 11:28 am
Tags:
Amylin, Bydureon, diabetes, Eli Lilly, Alkermes
Exenatide tQT Study Showed No Prolongation of QT Interval
Pipeline Review
Sat, 07/9/11 - 12:43 pm
Tags:
exenatide, Eli Lilly, diabetes, Byetta, Amylin, Alkermes, Bydureon
Let's Just Hope For No More FDA Surprises
Motley Fool
Sat, 07/9/11 - 12:39 pm
Tags:
FDA, Amylin, Eli Lilly, Alkermes, Novo Nordisk
Amylin trades higher on diabetes drug promise
Yahoo/AP
Sat, 07/9/11 - 10:52 am
Tags:
Amylin, diabetes, Bydureon
Amylin, Alkermes say diabetes drug safe for heart
Yahoo/AP
Thu, 07/7/11 - 10:13 pm
Tags:
diabetes, Amylin, Alkermes, Bydureon

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.